CD133-binding agents and uses thereof
US11220551B2 · kind B2 · utility
5Cited by
0References
27Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 19, 2017 |
| Grant date | Jan 11, 2022 |
| Priority date | — |
| Expiry date | Mar 21, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure is directed to novel CD133-binding agents. The disclosure is also directed to uses of novel CD133-binding agents for detecting CD133-expressing cells and/or quantitating levels of cellular CD133 expression, for targeting CD133-expressing cells, for decreasing levels of CD133 in CD133-expressing cells and for treating or preventing cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.